Category: Prescription Drugs
Prescription Drugs market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Medical Morphine
The 2025-2030 World Outlook for Medical Morphine This study covers the world outlook for medical morphine across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Antidepressant Drugs
The 2025-2030 World Outlook for Antidepressant Drugs This study covers the world outlook for antidepressant drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Antidepressants for Anxiety Disorders
The 2025-2030 World Outlook for Antidepressants for Anxiety Disorders This study covers the world outlook for antidepressants for anxiety disorders across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Antipsychotics
The 2025-2030 World Outlook for Antipsychotics This study covers the world outlook for antipsychotics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... Read More
-
The 2025-2030 World Outlook for Emergency Contraceptive Combination Pills
The 2025-2030 World Outlook for Emergency Contraceptive Combination Pills This study covers the world outlook for emergency contraceptive combination pills across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Orally Disintegrating Tablets (ODTs)
The 2025-2030 World Outlook for Orally Disintegrating Tablets (ODTs) This study covers the world outlook for orally disintegrating tablets (ODTs) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Diagnostic and Drugs
The 2025-2030 World Outlook for Breast Cancer Diagnostic and Drugs This study covers the world outlook for breast cancer diagnostic and drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Cystic Fibrosis Drugs
The 2025-2030 World Outlook for Cystic Fibrosis Drugs This study covers the world outlook for cystic fibrosis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Hemophilia a Drugs
The 2025-2030 World Outlook for Hemophilia a Drugs This study covers the world outlook for hemophilia a drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Hemorrhoidal Preparations
The 2025-2030 World Outlook for Hemorrhoidal Preparations This study covers the world outlook for hemorrhoidal preparations across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Decongestants
The 2025-2030 World Outlook for Decongestants This study covers the world outlook for decongestants across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More
-
The 2025-2030 World Outlook for Actinic Keratosis Treatments
The 2025-2030 World Outlook for Actinic Keratosis Treatments This study covers the world outlook for actinic keratosis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Statins
The 2025-2030 World Outlook for Statins This study covers the world outlook for statins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent s ... Read More
-
The 2025-2030 World Outlook for Hepatitis Drugs
The 2025-2030 World Outlook for Hepatitis Drugs This study covers the world outlook for hepatitis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Acne Medications
The 2025-2030 World Outlook for Acne Medications This study covers the world outlook for acne medications across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Hereditary Angioedema C1 Esterase Inhibitors
The 2025-2030 World Outlook for Hereditary Angioedema C1 Esterase Inhibitors This study covers the world outlook for hereditary angioedema C1 esterase inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.) ... Read More
-
The 2025-2030 World Outlook for Hepatitis C Therapies
The 2025-2030 World Outlook for Hepatitis C Therapies This study covers the world outlook for hepatitis c therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Addiction Treatments
The 2025-2030 World Outlook for Addiction Treatments This study covers the world outlook for addiction treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Multiple Sclerosis Treatments
The 2025-2030 World Outlook for Multiple Sclerosis Treatments This study covers the world outlook for multiple sclerosis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for HIV and AIDS Therapeutics
The 2025-2030 World Outlook for HIV and AIDS Therapeutics This study covers the world outlook for HIV and AIDS therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for HIV Drugs
The 2025-2030 World Outlook for HIV Drugs This study covers the world outlook for HIV drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the perce ... Read More
-
The 2025-2030 World Outlook for Pharmacy Automation
The 2025-2030 World Outlook for Pharmacy Automation This study covers the world outlook for pharmacy automation across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Depression Drugs
The 2025-2030 World Outlook for Depression Drugs This study covers the world outlook for depression drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for First Generation Antipsychotic Drugs for Schizophrenia
The 2025-2030 World Outlook for First Generation Antipsychotic Drugs for Schizophrenia This study covers the world outlook for first generation antipsychotic drugs for schizophrenia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Hodgkins Lymphoma Drugs
The 2025-2030 World Outlook for Hodgkins Lymphoma Drugs This study covers the world outlook for Hodgkins lymphoma drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
Research Assistance
